Skip to content
Dose Brief
Menu
No. 294 on the board · Grade C

NuuVim review

NuuVim is a Texas-based DTC telehealth program offering compounded semaglutide and tirzepatide in both injectable and oral forms — oral access is uncommon here — plus limited brand-name Ozempic and Zepbound.

Visit NuuVim Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
From $79/mo (all doses, compounded)
Tirzepatide
From $133/mo (all doses, compounded)
Coverage
Coverage not published
Brand-name
Yes
On the trackerNewnew to the tracker, no prior readingNew to the tracker on 1 August 2026. The published line reads From $79/mo (all doses, compounded) at our first reading; there is no earlier reading of ours to compare it against yet.

The scorecard

NuuVim scored on our six Brief Score factors. See the methodology.

Price Stability78/100
Supply Reliability61/100
Transparency72/100
Access Breadth62/100
Clinical Oversight54/100
Track Record31/100

What we like

  • Low compounded entry pricing — semaglutide from $79/mo, tirzepatide from $133/mo, flat all-dose pricing
  • Both injectable and oral compounded options for semaglutide and tirzepatide (oral access is uncommon)
  • LegitScript Certified and HIPAA-compliant
  • Two named compounding pharmacy partners (Hallandale Pharmacy and Pharmacy Hub), both vetted in our directory
  • Operating legal entity disclosed: NuuVim LLC, Texas governing law

The caveats

  • No founder, CEO, medical director, or pharmacist-in-charge named
  • Refund and cancellation policy not surfaced on the site
  • Compounded medications are not FDA-approved
  • Doesn't disclose which pharmacy fills which drug or form
  • FDA issued this company a warning letter dated 19 March 2025; the letter is public in FDA's warning-letter database

The brief

Best for: Readers who want low-cost compounded GLP-1s (injection or oral), flat all-dose pricing. NuuVim is a Texas-based DTC telehealth program offering compounded semaglutide and tirzepatide in both injectable and oral forms — oral access is uncommon here — plus limited brand-name Ozempic and Zepbound.

Ranked #294 of 495 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Closest on the board

The desks scoring nearest NuuVim — the realistic shortlist if you're weighing it.

Weighing NuuVim against one desk in particular? We file it head to head with our top-ranked pick in CoreAge Rx vs NuuVim, and every desk that outranks it is listed on the NuuVim alternatives board.

More desks we track (24)

464 more are filed too — see every desk we track, ranked.

Pricing, states and verification reflect NuuVim's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on NuuVim's site. Not medical advice; see our disclosure.

← Back to all rankings